BSE filing, BSE: 518053. Summary written from the filing by ALFA Finder's alert engine.
Sri Chakra Cement Ltd: key numbers
- Share price
- ₹32.10
- Market cap
- ₹28.89 Cr
- Revenue (annual)
- ₹128.6 Cr
- Net profit (annual)
- ₹-23.09 Cr
- P/E (TTM)
- -1.8×Sector 32.4×
- Promoter holding
- 51.61%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Sri Chakra Cement Ltd
All →Sri Chakra Cement Other Announcement
Sri Chakra Cement Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, as required by regulatory compliance norms.
Sri Chakra Cement Management Change
Mr. Sriram Kapilavai has resigned as Whole-time Director of Sri Chakra Cement Limited, effective August 25, 2026. The company has formally disclosed this resignation.
Sri Chakra Cement Annual General Meeting
Sri Chakra Cement Limited held its 44th Annual General Meeting on August 19, 2026. The company discussed various agenda items, including the adoption of financial statements.
Sri Chakra Cement Management Change
Sri Chakra Cement Limited has appointed Sri Vijay Kumar Kapilavai as the new Chief Financial Officer. The appointment is effective immediately from August 14, 2026.
Sri Chakra Cement Q1 FY27 Results: Turns Profitable, Net Profit ₹0.3 Cr
Sri Chakra Cement Ltd reported revenue from operations of ₹26.3 Cr (-29.5% YoY) and net profit of ₹0.3 Cr for Q1 FY27.
- Key figure
- Net profit ₹0.3 Cr
Sri Chakra Cement Board Meeting Outcome
The Board approved the Q1 FY2026-27 unaudited financial results and appointed Sri Vijay Kumar Kapilavai as the new CFO.
Other board meeting date announcements
All →HCP Plastene Bulkpack Board Meeting Date
HCP Plastene Bulkpack scheduled a board meeting for 06 November 2026. It will consider unaudited results for the quarter and half year ending 30 September 2026.
Ultracab (India) Board Meeting Date
Ultracab (India) Ltd intimated that its Board meeting is scheduled for 04-Nov-2026 to consider unaudited standalone financial results. No results or financial figures are disclosed in this advance notice.
Texmaco Infrastructure & Holdings Board Meeting Date
Texmaco has scheduled a Board meeting on November 5, 2026, to approve Q2 and H2 FY27 financial results. Trading window stays closed for insiders pending results declaration.
Astonea Labs Board Meeting Date
Astonea Labs intimated that its Board is scheduled on 14 Nov 2026 to consider unaudited half-year results. The trading window remains closed until 48 hours post-announcement.
AstraZeneca Pharma India Board Meeting Date
AstraZeneca Pharma India scheduled its board meeting for 5 Nov 2026 to approve Q2/H1 FY27 results. The trading window remains closed until 7 Nov 2026.
Mafatlal Industries Board Meeting Date
Mafatlal Industries updated that its 4 November 2026 board meeting will consider an interim dividend for FY27. Record date, if approved, is 13 November 2026.